Core Scientific Inc [CORZ] stock is trading at $18.36, down -2.81%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CORZ shares have gain 5.03% over the last week, with a monthly amount glided 35.30%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Core Scientific Inc [NASDAQ: CORZ] stock has seen the most recent analyst activity on January 06, 2026, when BTIG Research upgraded its rating to a Buy but kept the price target unchanged to $23 for it. Previously, Citizens JMP upgraded its rating to Mkt Outperform on December 18, 2025, and kept the price target unchanged to $30. On October 28, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $25 on the stock. Roth Capital upgraded its rating to a Buy but stick to its price target of $23.50 on October 23, 2025. B. Riley Securities upgraded its rating to a Buy but $30 remained the price target by the analyst firm on October 22, 2025. In a note dated July 22, 2025, Arete initiated an Buy rating and provided a target price of $20 on this stock.
Core Scientific Inc [CORZ] stock has fluctuated between $6.20 and $23.63 over the past year. Currently, Wall Street analysts expect the stock to reach $27.38 within the next 12 months. Core Scientific Inc [NASDAQ: CORZ] shares were valued at $18.36 at the most recent close of the market. An investor can expect a potential return of 49.13% based on the average CORZ price forecast.
Analyzing the CORZ fundamentals
Core Scientific Inc [NASDAQ:CORZ] reported sales of 334.18M for the trailing twelve months, which represents a drop of -14.95%. Gross Profit Margin for this corporation currently stands at 0.07% with Operating Profit Margin at -0.52%, Pretax Profit Margin comes in at -2.3%, and Net Profit Margin reading is -2.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is 0.96 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Core Scientific Inc’s Current Ratio is 1.58. Further, the Quick Ratio stands at 1.58, while the Cash Ratio is 0.68. Considering the valuation of this stock, the price to sales ratio is 17.03 and price to earnings (TTM) ratio is 131.80.
Transactions by insiders
Recent insider trading involved Weiss Eric Stanton, Director, that happened on Nov 04 ’25 when 5000.0 shares were purchased. See remarks, DUCHENE TODD M completed a deal on Jun 25 ’25 to sell 7759.0 shares. Meanwhile, Officer DUCHENE TODD M bought 7759.0 shares on Jun 25 ’25.
